(Q38073084)

28 August 2017

1 reference

title

A review of pharmacotherapy for chronic low back pain with considerations for sports medicine (English)

1 reference

28 August 2017

0 references

0 references

John H Peniston

1

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

The Physician and Sportsmedicine

28 August 2017

published in

1 reference

28 August 2017

volume

40

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

21-32

1 reference

Management of back pain in athletes

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Back pain and radiological changes in the thoraco-lumbar spine of athletes. A long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Lower back pain in golfers: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Prevalence of low back pain and associated occupational factors among Chinese coal miners

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Low back pain among Irish farmers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Chronic non-specific low back pain - sub-groups or a single mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

The rising prevalence of chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Low back pain in adolescent female rowers: a multi-dimensional intervention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Exercise therapy for chronic nonspecific low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Lower back pain in the athlete: common conditions and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

A systematic review of paracetamol for non-specific low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Epidemiological features of chronic low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

The differential effects of core stabilization exercise regime and conventional physiotherapy regime on postural control parameters during perturbation in patients with movement and control impairment chronic low back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Low back pain in young female gymnasts and the effect of specific segmental muscle control exercises of the lumbar spine: a prospective controlled intervention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Resistance training in musculoskeletal rehabilitation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Effect of therapeutic exercise versus manual therapy on athletes with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Treatment options for low back pain in athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Opioid Therapy for Osteoarthritis and Chronic Low Back Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Chapter 4. European guidelines for the management of chronic nonspecific low back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

National collegiate athletic association division I athletes' use of nonprescription medication

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Acetaminophen hepatotoxicity and acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Focus on the COX-1 and COX-2 agents: renal events of nonsteroidal and anti-inflammatory drugs-NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Non-narcotic analgesic dose and risk of incident hypertension in US women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Celecoxib, NSAIDs and the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Potential dangers from topical preparations containing methyl salicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Adverse effect of topical methylsalicylate ointment on warfarin anticoagulation: an unrecognized potential hazard

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Potentiation of warfarin anticoagulation associated with topical methyl salicylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

The effect of antidepressant treatment on chronic back pain: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Systematic Review of Antidepressants in the Treatment of Chronic Low Back Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Efficacy and safety of duloxetine in patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

A review of forensic implications of opioid prescribing with examples from malpractice cases involving opioid-related overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Development and validation of the Current Opioid Misuse Measure

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Urine toxicology testing in chronic pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Opioid switching and rotation in primary care: implementation and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Injury, pain, and prescription opioid use among former National Football League (NFL) players

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

The athlete biological passport

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

The role of the Back Rx exercise program in diskogenic low back pain: a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Opioid therapy for chronic noncancer back pain. A randomized prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Open-label study on the long-term efficacy, safety, and impact on quality of life of OROS hydromorphone ER in patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Transdermal fentanyl as treatment for chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Opioids in renal failure and dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Opioid rotation in the treatment of joint pain. A review of 67 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Opioid switching: a systematic and critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Tapentadol extended release: in adults with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, double-blind, 6-week studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Investigations into the drug-drug interaction potential of tapentadol in human liver microsomes and fresh human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

(-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Acute opioid administration improves work-related exercise performance in patients with chronic back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Functionality and health-status benefits associated with reduction of osteoarthritis pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Functional outcomes in patients with chronic nonmalignant pain on long-term opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

Effective pain relief facilitates exercise therapy : Results of a multicenter study with controlled-release oxycodone in patients with movement pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1985

21 January 2018

Identifiers

DOI

10.3810/PSM.2012.11.1985

1 reference

28 August 2017

1 reference